GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
China Medical Technologies, Inc. (CMEDQ) [hlAlert]

Rating:
Buy CMED
down 75.31 %

China Medical Technologies, Inc. (CMED) rated Buy by Deutsche Bank

Posted on: Wednesday,  Aug 25, 2010  3:25 PM ET by Deutsche Bank

Deutsche Bank rated Buy China Medical Technologies, Inc. (OTCBB: CMEDQ) on 08/25/2010, when the stock price was $10.37.
Since then, China Medical Technologies, Inc. has lost 75.31% as of 11/08/2012's recent price of $2.56.
If you would have followed this Deutsche Bank's recommendation on CMEDQ, you would have lost 75.31% of your investment in 806 days.

China Medical Technologies, Inc. (China Medical) is a People?s Republic of China-based medical device company, which develops, manufactures and markets advanced immunodiagnostic and molecular diagnostic products utilizing enhanced chemiluminescence immunoassay (ECLIA) technology, fluorescent in situ hybridization (FISH) technology and surface plasmon resonance (SPR) technology. The in-vitro diagnostics (IVD) products are used to detect and monitor various diseases and disorders through laboratory evaluation and analysis of blood, urine or other body fluids. The Company operates in two business segments: immunodiagnostic systems and molecular diagnostic systems. Immunodiagnostic systems include ECLIA analyzers and reagent kits. The molecular diagnostic systems include FISH imaging analyzers and probes. It also includes SPR systems and human papillomavirus- deoxyribonucleic acid (HPV-DNA) chips. The wholly owned subsidiary of the Company is CMED ECLIA Diagnostic Technology Ltd.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/25/2010 3:25 PM Buy
None
10.37
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy